Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: An updated systematic review

Journal of the Royal Society of Medicine

Volumn 99, Issue 10, 2006, Pages 506-520

  Chambers, Duncan ^a   Bagnall, Anne Marie ^b   Hempel, Susanne ^a   Forbes, Carol ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b LEEDS METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMPLIGEN; CLONIDINE; CORTICOSTEROID; DEXAMPHETAMINE; FLUDROCORTISONE ACETATE; FLUOXETINE; GALANTAMINE; GROWTH HORMONE; HYDROCORTISONE; IMMUNOGLOBULIN; INTERFERON; MAGNESIUM; MELATONIN; METHISOPRINOL; MOCLOBEMIDE; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; STAPHYLOCOCCUS TOXIN; SULBUTIAMINE; TERFENADINE;

BEHAVIOR THERAPY; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; DATA EXTRACTION; EXERCISE; HUMAN; MEDICAL LITERATURE; REVIEW; SUPPLEMENTATION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 33750627941     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.99.10.506     Document Type: Review

References (104)

1. Sharpe MC, Archard LC, Banatvala JE, et al. A report-chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-21
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-9
3. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: A prospective primary care study. Am J Public Health 1997;87:1449-55
4. CFS/ME Working Group. A report of the CFS/ME Working Group: Report to the Chief Medical Officer of an Independent Working Group. London: Department of Health, 2002
5. Price JR, Couper J. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database of Systematic Reviews 1998: CD001
6. Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews 2004:CD003
7. Ross SD, Estok RP, Frame D, Stone LR, Ludensky V, Levine CB. Disability and chronic fatigue syndrome: a focus on function. Arch Intern Med 2004;164:1098-107
8. Mulrow CD, Ramirez G, Cornell JE, Allsup K. Defining and managing chronic fatigue syndrome. Evidence Report: Technology Assessment (Summary) 2001:1-4
9. Bagnall A-M, Whiting P, Wright K, Sowden AJ. The Effectiveness of Interventions Used in the Treatment/Management of chronic Fatigue Syndrome and/or Myalgic Encephalomyelitis in Adults and Children. York, UK: NHS Centre for Reviews and Dissemination, University of York; 2002: Report No 22
10. NHS Centre for Reviews and Dissemination. Undertaking Systematic Reviews of Research on Effectiveness: CRD's Guidance For Those Carrying Out or Commissioning Reviews. 2nd edn. York: NHS Centre for Reviews and Dissemination; 2001: Report No 4
11. DuBois RE. Gamma globulin therapy for chronic mononucleosis syndrome. AIDS Res 1986;2(Suppl 1):S191-5
12. Weatherley-Jones E, Thomas K. A randomised, controlled trial of homeopathic treatment for chronic fatigue syndrome [abstract). 17th Annual Meeting of the International Society of Technology Assessment in Health Care: Building Bridges Between Policy, Providers, Patients and Industry. June 3-6 2001:67
13. Siddiqui M, Kadri NN, Hee TT, et al. Clonazepam: an effective treatment of neurally mediated symptoms in patients with chronic fatigue syndrome. Chest 2000;118:219S
14. Antoni MH, Weiss D. Do stressors and stress management intervention affect physical symptoms and physiological functioning in chronic fatigue syndrome? Psychosom Med 2002;64:5A
15. Antoni M, Chadler T. Symposium synopsis: The effects and underlying mechanisms of cognitive behavioral interventions in Chronic Fatigue Syndrome. Psychosom Med 2002;64:5
16. Bazelmans E, Prins J, Bleijenberg G. Cognitive behavior therapy for active and for passive CFS patients / Cognitieve gedragstherapie bij relatief actieve en bij passieve CVS-patienten. Gedragstherapie 2002;35:191-204
17. Bleichhardt G, Timmer B, Rief W. Predictors for short- and long-term outcome in patients with somatoform disorders after cognitive-behavioral therapy. Zeitschrift Fur Klinische Psychologie Psychiatrie Und Psychotherapie 2005;53:40-58
18. Janu L. The effect of care on patients with chronic fatigue syndrome. The open randomized comparison of three antidepressants. J Psychosom Res 2002;52:328-28
19. Kurek JN. Treatment of chronic fatigue syndrome with methylphenidate. Dissertation Abstracts International: Section B: The Sciences and Engineering 2001;61:5
20. Lieberman S. Antiviral intervention for chronic fatigue syndrome. Townsend Letter for Doctors and Patients 2004;248:74-6
21. Schollmann C. Sage flower extract against fatigue syndrome and iron deficiency. Arztezeitschrift fur Naturheilverfahren 2001;42:700+02
22. Strang JM. Treatment of chronic fatigue syndrome: a cognitive-behavioral approach to enhance personal mastery. Dissertation Abstracts International Section A: Humanities and Social Sciences 2002;63:1
23. Surawy C, Roberts J, Silver A. The effect of mindfulness training on mood and measures of fatigue, activity, and quality of life in patients with chronic fatigue syndrome on a hospital waiting list: a series of exploratory studies. Behavioural and Cognitive Psychotherapy 2005;33:103-09
24. Van Hoof E, Coomans D, De Becker R, De Meirleir K, Cluydts R. Hyperbaric oxygen therapy for chronic systemic infections in chronic fatigue syndrome. Int J Psychophysiol 2002;45:82-83
25. Van Hoof E, Coomans D, De Becker P, Meeusen R, Cluydts R, De Meirleir K. Hyperbaric Therapy in Chronic Fatigue Syndrome. J Chronic Fatigue Syndr 2003;11:37-49
26. Waldman PN. Vitamin therapy in the treatment of depression associated with chronic fatigue syndrome. Dissertation Abstracts International: Section B: The Sciences and Engineering 2001;61:5
27. Wright B, Ashby B, Beverley D, et al. A feasibility study comparing two treatment approaches for chronic fatigue syndrome in adolescents. Arch Dis Child 2005;90:369-72
28. Dotsenko VA, Mosiichuk LV, Paramonov AE. [Biologically active food additives for correction of the chronic fatigue syndrome). Vopr Pitan 2004;73:17-21
29. Stulemeijer M, de Jong LW, Fiselier TJ, Hoogveld SW, Bleijenberg G. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. BMJ 2005;330:14
30. Moss-Morris R, Sharon C, Tobin R, Baldi JC. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol 2005;10:245-59
31. Wallman KE, Morton AR, Goodman C, Grove R, Guilfoyle AM. Randomised controlled trial of graded exercise in chronic fatigue syndrome. Med J Aust 2004;180:444-8
32. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997;314:1647-52
33. Powell P, Bentall RP, Nye FJ, Edwards RH. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ 2001;322:387-90
34. Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 1998;172:485-90
35. Diaz-Mitoma F, Turgonyi E, Kumar A, Lim W, Larocque L, Hyde BM. Clinical improvement in chronic fatigue syndrome is associated with enhanced natural killer cell-mediated cytotoxicity: the results of a pilot study with Isoprinosine. J Chronic Fatigue Syndr 2003;11:71-93
36. Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, Gottfries CG. Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome-a randomised controlled trial. European Journal of Pain: EJP 2002;6:455-66
37. Blacker CVR, Greenwood DT, Wesnes KA, et al. Effect of galantamine hydrobromide in chronic fatigue syndrome: A randomized controlled trial. JAMA 2004;292:1195-
38. Cleare A. Hydrocortisone treatment in CFS. Int J Neuropsychopharmacol 2002;5(Suppl 1):S35
39. Blockmans D, Persoons P, Van Houdenhove B, Lejeune M, Bobbaers H. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Am J Med 2003;114:736-41
40. Kakumanu S, Mende C, Lehman E, Yeageer M, Craig T. The effect of topical nasal corticosteroids in patients with chronic fatigue syndrome and rhinitis. J Allergy Clin Immunol 2001;107:S153
41. Weatherley-Jones E, Nicholl JP, Thomas KJ, et al. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. J Psychosom Res 2004;56:189-97
42. Awdry R. Homeopathy may help ME. Int J Alternat Complement Med 1996;14:12-6
43. Vermeulen RC, Scholte HR. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. Psychosom Med 2004;66:276-82
44. Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990;82:209-16
45. Cox IM, Campbell MJ, Dowson D, Davies S, Walden RJ. Magnesium and chronic fatigue syndrome. Lancet 1991;337:1295
46. Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 1999;99:112-6
47. Sharpe M, Hawton K, Simkin S, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial. BMJ 1996;312:22-6
48. Prins JB, Bleijenberg G, Bazelmans E, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001;357:841-7
49. Viner R, Gregorowski A, Wine C, et al. Outpatient rehabilitative treatment of chronic fatigue syndrome (CFS/ME). Arch Dis Child 2004;89:615-9
50. Rowe KS. Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J Psychiatr Res 1997;31:133-47
51. Straus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med 1988;319:1692-8
52. Deale A, Husain K, Chalder T, Wessely S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry 2001;158:2038-42
53. Powell P, Bentall RP, Nye FJ, Edwards RH. Patient education to encourage graded exercise in chronic fatigue syndrome. 2-year follow-up of randomised controlled trial. Br J Psychiatry 2004;184:142-6
54. Whitehead L, Campion P. Can general practitioners manage Chronic Fatigue Syndrome? A controlled trial. J Chronic Fatigue Syndr 2002;10:55-64
55. Royal Australasian College of Physicians. Chronic fatigue syndrome. Clinical practice guidelines - 2002. Med J Aust 2002;176:S19-55
56. Royal College of Paediatrics and Child Health. Evidence Based Guideline for the Management of CFS/ME (Chronic Fatigue Syndrome/Myalgic Encephalopathy) in Children and Young People. London: Royal College of Paediatrics and Child Health; 2004
57. Department of Health. Organising and Delivering Psychological Therapies. London: Department of Health; 2004
58. Action for M.E. Severely Neglected: M.E. in the UK-Membership Survey. London: Action for M.E.; 2001
59. Wearden AJ, Riste L, Dowrick C, et al. Fatigue Intervention by Nurses Evaluation - the FINE trial. A randomised controlled trial of nurse led self-help treatment for patients in primary care with chronic fatigue syndrome: study protocol. BMC Medicine 2006;4:9
60. Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry 1997;154:408-14
61. Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med 1993;94:197-203
62. Taylor RR, Braveman B, Hammel J. Developing and evaluating community-based services through participatory action research: two case examples. Am J Occup Ther 2004;58:73-82
63. Cox DL. An Evaluation of an Occupational Therapy Inpatient Intervention for Chronic Fatigue Syndrome [Ph.D]. London: King's College London, 1999
64. Cox DL. Chronic fatigue syndrome: An evaluation of an occupational therapy inpatient intervention. Br J Occup Ther 2002;65:461-68
65. Friedberg F, Krupp LB. A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clin Infect Dis 1994;18(Suppl 1):S105-10
66. Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990;89:554-60
67. Lloyd A, Hickie I, Wakefield D, Boughton C, Dwyer J. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med 1990;89:561-8
68. Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997;l03:38-43
69. Andersson M, Bagby JR, Dyrehag LE, Gottfries CG. Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome. European Journal of Pain: EJP 1998;2:133-42
70. See DM, Tilles JG. α-Interferon treatment of patients with chronic fatigue syndrome. Immunol Invest 1996;25:153-64
71. Brook MG, Bannister BA, Weir WR. Interferon-alpha therapy for patients with chronic fatigue syndrome. J Infect Dis 1993;168:791-2
72. Strayer DR, Carter WA, Brodsky I, et al. A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome. Clin Infect Dis 1994;18(Suppl 1):S88-95
73. Steinberg P, McNutt BE, Marshall P, et al. Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. J Allergy Clin Immunol 1996;97:119-26
74. Lerner AM, Zervos M, Chang CH, et al. A small, randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome [comment]. Clin Infect Dis 2001;32:1657-8
75. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999;353:455-8
76. McKenzie R, O'Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial. JAMA 1998;280:1061-66
77. Rowe PC, Calkins H, DeBusk K, et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 2001;285:52-9
78. Peterson PK, Pheley A, Schroeppel J, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 1998;158:908-14
79. Hickie IB, Wilson AJ, Wright J, Bennett BK, Wakefield D, Lloyd AR. A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry 2000;61:643-4-8
80. Vercoulen J, Swanink CMA, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996;347:858-61
81. Natelson BH, Cheu J, Hill N, et al. Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome. Xeuropsychobiology 1998;37:150-4
82. Snorrason E, Geirsson A, Stefansson K. Trial of a selective acetylcholinesterase inhibitor, galanthamine hydrobromide, in the treatment of chronic fatigue syndrome. J Chronic Fatigue Syndr 1996;2:35-54
83. Forsyth LM, Preuss HG, MacDowell AL, Chiazze L Jr, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol 1999;82:185-91
84. Santaella ML, Font I, Disdier OM. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome. P R Health Sci J. 2004;23:89-93
85. Morriss RK, Robson MJ, Deakin J. Neuropsychological performance and noradrenaline function in chronic fatigue syndrome under conditions of high arousal. Psychopharmacology (Berl) 2002; 163:166-73
86. Natelson BH, Cheu J, Pareja J, Ellis P, Policastro T, Findley TW. Randomized, double blind, controlled placebo phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology (Berl) 1996;124:226-30
87. Tiev KP, Cabane J, Imbert JC. Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo. Rev Med Interne 1999;20:912-8
88. Olson LG, Ambrogetti A, Sutherland DC. A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome. Psychosomatics 2003;44:38-43
89. Moorkens G, Wynants H, Abs R. Effect of growth hormone treatment in patients with chronic fatigue syndrome: A preliminary study. Growth Horm IGF Res 1998;8:131-33
90. Williams G, Waterhouse J, Mugarza J, Minors D, Hayden K. Therapy of Orcadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy. Eur J Clin Invest 2002;32:831-7
91. Field TM, Sunshine W, Hernandez-Reif M, et al. Massage therapy effects on depression and somatic symptoms in chronic fatigue syndrome. J Chronic Fatigue Syndr 1997;3:43-51
92. Perrin RN, Edwards J, Hartley P. An evaluation of the effectiveness of osteopathic treatment on symptoms associated with Myalgic Encephalomyelitis. A preliminary report. J Med Eng Technol 1998;22:1-13
93. Brouwers FM, Van Der Werf S, Bleijenberg G, Van Der Zee L, Van Der Meer JW. The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomized controlled trial. QJM 2002;95:677-83
94. Martin RWY, Ogston SA, Evans JR. Effects of vitamin and mineral supplementation on symptoms associated with chronic fatigue syndrome with Coxsackie B antibodies. J Nutr Med 1994;4:11-23
95. Stewart W, Rowse C. Supplements help ME says Kiwi study. J Altern Complement Med 1987;5:19-20
96. % Kaslow JE, Rucker L, Onishi R. Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. Arch Intern Med 1989;149:2501-3
97. Ockerman PA. Antioxidant treatment of chronic fatigue syndrome. Clinical Practice of Alternative Medicine 2000;1:88-91
98. De Becker P, Nijs J, Van HE, McGregor N, De MK. A double-blind, placebo-controlled study of acclydine in combination with amino acids in patients with chronic fatigue syndrome. AHMF Proceedings, "Myalgic Encephalopathy/Chronic Fatigue Syndrome The Medical Practitioners' Challenge in 2001". 2001
99. Rothschild PR, Huertas JG. Ambulatory naturopathic treatment of chronic fatigue immune deficiency syndrome (CFIDS) with RM-10 caplets. Progress in Nutrition 2002;4:77-96
100. Teitelbaum JE, Bird B, Greenfield RM, Weiss A, Muenz L, Gould L. Effective treatment of chronic fatigue syndrome and fibromyalgia - A randomized, double-blind, placebo-controlled, intent-to-treat study. J Chronic Fatigue Syndr 2001;8:3-28
101. Marlin RG, Anchel H, Gibson JC, Goldberg WM, Swinton M. An evaluation of multidisciplinary intervention for chronic fatigue syndrome with long-term follow-up, and a comparison with untreated controls. Am J Med 1998;105:110S-14S
102. Goudsmit E. Learning to Cope with Post-Infectious Fatigue Syndrome, a Follow-up Study. Brunel, 1996
103. Schlaes J, Jason L. A buddy/ mentor program for PWCs. CFIDS Chronicle 1996:21-5
104. Söderberg S, Evengård B. Short-term group therapy for patients with chronic fatigue syndrome. Psychother Psychosom 2001;70:108-11